|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of goods sold (excluding amortization expense - See Note 15) | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Impairment charges | |||||
| Restructuring and related charges, net | |||||
| Combination, integration and other acquisition-related expenses | |||||
| Operating income | |||||
| Other (expense) income, net | |||||
| Interest expense | |||||
| Income before taxes and equity in net income of associated companies | |||||
| Taxes on income before equity in net income of associated companies | |||||
| (Loss) income before equity in net income of associated companies | |||||
| Equity in net income of associated companies | |||||
| Net (loss) income | |||||
| Less: Net income attributable to noncontrolling interest | |||||
| Net (loss) income attributable to Quaker Chemical Corporation | |||||
| Per share data: | |||||
| Net (loss) income attributable to Quaker Chemical Corporation common shareholders– basic (in dollars per share) | |||||
| Net (loss) income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) | |||||
Loading...